Boehringer Ingelheim Pharmaceuticals, Inc. et al. vs. Genentech, Inc.
Explore the PTAB proceeding IPR2017-02032 filed by Boehringer Ingelheim Pharmaceuticals, Inc. et al. on 2017-08-31. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-02032
Filing Date
2017-08-31
Accorded Filing Date
2017-08-31
Institution Decision Date
2018-03-29
Last Modified Date
2024-01-11
Proceeding Type
IPR
Termination Date
2018-07-31
Trial Status
Terminated
Parties & Counsel
Petitioner
Patent Owner / Respondent
Genentech, Inc.
Represented By
Cavanaugh, Davidet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Terminated
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,407,213 Asserted | Asserted Patent | View Official Patent → |
Samsung Bioepis Co., Ltd. v. Genentech, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. et al. v. Genentech, Inc.
Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc.
Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc.
Genentech, Inc. v. Immunex Rhode Island Corp.
Genentech, Inc. v. Samsung Bioepis Co., Ltd.